1 / 5

Artificial T-Cell Receptors Market Size, Industry Trends, Share and Forecast 2019-2025

Artificial T-cell receptors provide enhanced ability to T-cells for targeting a specific protein.

nabeelomr
Télécharger la présentation

Artificial T-Cell Receptors Market Size, Industry Trends, Share and Forecast 2019-2025

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Artificial T-cell receptors provide enhanced ability to T-cells for targeting a specific protein. These receptors are often called as Chimeric Antigen Receptor (CAR) or Chimeric T-Cell Receptor which are bound to surface of T-cells and serve the purpose of alerting immune systems about the impending virus attack. The artificial T-cell receptors market is expected to grow at an impressive growth rate over the forecast period. A major factor that augments the growth of the market is the rising prevalence of cancer disease across the globe. Moreover, increasing incidence of immunological diseases and chronic diseases such as cardiovascular diseases across the globe is further fueling the market growth. Get Free Sample Copy @ https://www.omrglobal.com/request-sample/artificial-t-cell- receptors-market Significant prevalence of cancer disease has been observed in the US. According to the American Cancer Society in 2017, it was estimated that out of total 600,920 cancer deaths in the US, around 190,500 would be caused by cigarette smoking. In addition, it was estimated by the World Cancer Research Fund that 20% of cancers are caused by factors such as physical inactivity, excess body weight, excess alcohol consumption, and poor nutrition. Moreover, as per American Cancer Society in 2017, 87% of all the cancers in the US were diagnosed in people with age 50 years and above. However, these cancers were preventable. Additionally, colorectal and cervical cancers can be prevented by screening and by removal of precancerous lesions. Screening also has reduced the mortality rate significantly for the cancers of colon, breast, and lung. These facts and figures reflect the need for less-toxic forms of immune-based cellular therapy such as T-cell receptors therapy to treat cancer which ultimately results in positive market growth. Browse for Full Report at: https://www.omrglobal.com/industry-reports/artificial-t-cell- receptors-market

  2. 5. Market Segmentation 5.1. Global Artificial T-Cell Receptors Market by Disease 5.1.1. Cancer 5.1.1.1. Acute Lymphoblastic Leukemia (ALL) 5.1.1.2. Diffuse Large B-Cell Lymphoma 5.1.1.3. Other Cancer Types 5.1.2. Immunological Disorders 5.2. Global Artificial T-Cell Receptors Market by Therapy 5.2.1. Autologous 5.2.2. Allogenic 5.3. Global Artificial T-Cell Receptors Market by End-User 5.3.1. Research Institutes 5.3.2. Hospitals 5.3.3. Biotech Companies 6. Regional Analysis 6.1. North America 6.1.1. United States 6.1.2. Canada

  3. 6.2. Europe 6.2.1. UK 6.2.2. Germany 6.2.3. Italy 6.2.4. Spain 6.2.5. France 6.2.6. Rest of Europe 6.3. Asia-Pacific 6.3.1. China 6.3.2. India 6.3.3. Japan 6.3.4. Rest of Asia-Pacific 6.4. Rest of the World 7. Company Profiles 7.1. Adaptive Biotechnologies Corp. 7.2. Athenex, Inc. 7.3. Blubird Bio, Inc. 7.4. Cabaletta Bio, Inc.

  4. 7.5. Celgene Corp. 7.6. Cell Medica Ltd. 7.7. Eli Lilly & Co. 7.8. Juno Therapeutics, Inc. 7.9. Kite Pharma, Inc. 7.10. Lonza Group Ltd. 7.11. Medicomp Systems, Inc. 7.12. Medigene AG 7.13. NexImmune Inc. 7.14. Novartis AG 7.15. Oxford BioMedica PLC 7.16. Pfizer, Inc. 7.17. Precision Biosciences, Inc. 7.18. STEMCELL Technologies Inc. 7.19. TCR² Therapeutics Inc. 7.20. Thermo Fisher Scientific, Inc. 7.21. Unum Therapeutics, Inc.

  5. For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/artificial-t-cell-receptors-market About Orion Market Research Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. Media Contact: Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +91 780-304-0404

More Related